Skip to main content
. 2022 Aug 17;31(8):1127–1136. doi: 10.1089/jwh.2020.9011

Table 1.

Baseline Demographics of Sample (N = 443)

Characteristic Cases (n = 220) Controls (n = 223)
Current age (years), mean (SD) 29.6 (5.3) 32.7 (5.1)
Reference age (years), mean (SD) 21.2 (5.5) 21.4 (5.6)
Race, n (%)
 White 203 (92.3) 207 (92.8)
 Non-white 17 (7.7) 16 (7.2)
Age (years) of menarche, n (%)
 ≤10 16 (7.3) 20 (9.0)
 11 34 (15.5) 25 (11.2)
 12 59 (26.8) 69 (30.9)
 13 58 (26.4) 48 (21.5)
 14 30 (13.6) 41 (18.4)
 ≥15 23 (10.4) 20 (9.0)
Age (years) of first vaginal intercourse (5 cases and 5 controls missing), n (%)
 <16 44 (20.0) 48 (21.5)
 16–17 53 (24.1) 64 (28.7)
 ≥18 118 (53.6) 106 (47.5)
Lifetime vaginal intercourse partners (6 cases and 1 control missing), n (%)
 ≤2 62 (28.2) 65 (29.2)
 3–6 66 (30.0) 56 (25.1)
 7–12 48 (21.8) 56 (25.1)
 >12 38 (17.3) 45 (20.2)
History of physical or sexual abuse before age 11a (4 cases missing), n (%)
 None 88 (40.0) 108 (48.4)
 Moderate 40 (18.2) 54 (24.2)
 Severe 88 (40.0) 61 (27.4)
History of anxiety (2 cases and 1 control missing), n (%)
 Yes, diagnosed 66 (30.0) 31 (13.9)
 Yes, not diagnosed 27 (12.3) 29 (13.9)
 No 125 (56.8) 162 (72.7)
History of depression (2 controls missing), n (%)
 Yes, diagnosed 69 (31.4) 52 (23.3)
 Yes, not diagnosed 15 (6.8) 24 (10.8)
 No 136 (61.8) 145 (65.0)
History of bacterial vaginosis, n (%)
 Yes 29 (13.2) 17 (7.6)
 No 191 (86.8) 206 (92.4)
Ever had a urinary tract infection, n (%)
 Yes 98 (44.6) 66 (30.1)
 No 122 (55.5) 153 (69.9)
History of chronic constipation (1 control missing), n (%)
 Yes 20 (9.1) 5 (2.2)
 No 200 (90.9) 217 (97.3)
Any allergies to medications (1 case and 1 control missing), n (%)
 Yes 78 (35.5) 50 (22.4)
 No 141 (64.1) 172 (77.1)
History of chronic pain or fatigue disordersb, n (%)
 Yes 62 (28.2) 21 (9.4)
 No 158 (71.8) 202 (90.6)
Hormonal contraceptive use before age 18, n (%)
 Yes 147 (66.8) 128 (57.4)
 No 73 (33.2) 95 (42.6)
Hormonal contraceptive use in the year before reference agec, n (%)
 Yes 155 (70.5) 122 (54.7)
 No 65 (29.6) 101 (45.3)
Hormonal contraceptive use at time of survey, n (%)
 Yes 107 (48.6) 87 (39.0)
 No 113 (51.4) 136 (61.0)
Endometriosis, n (%)
 Yes 27 (12.3) 13 (5.8)
 No 193 (87.7) 210 (94.2)
Polycystic ovarian syndrome, n (%)
 Yes 10 (4.6) 14 (6.4)
 No 210 (95.5) 205 (93.6)
Age (years) of first tampon use (10 cases and 3 controls missing), n (%)
 ≤10 2 (0.9) 1 (0.5)
 11 6 (2.7) 10 (4.5)
 12–13 67 (30.5) 59 (26.5)
 14 37 (16.8) 47 (21.1)
 ≥15 98 (44.6) 103 (46.2)
Pain or difficulty with first tampon use (1 case and 1 control missing), n (%)
 Never used tampons 5 (2.3) 2 (0.9)
 No difficulty/difficulty, but no pain 51 (23.2) 137 (61.4)
 Difficulty and some pain 106 (48.2) 73 (32.7)
 Difficulty, with great pain 57 (25.9) 10 (4.5)
Ever stopped tampon use due to pain (1 case missing), n (%)
 Yes 98 (44.6) 9 (4.0)
 No 121 (55.0) 214 (96.0)
a

Categorization of abuse: none, no incidents of abuse; moderate, one to four instances of physical or sexual abuse; severe, five or more instances of physical or sexual abuse.

b

Chronic pain or fatigue disorders included interstitial cystitis, fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and temporomandibular joint disorder.

c

Reference age was the year of onset of vulvar pain for cases with vulvodynia and the same age for matched controls.

SD, standard deviation.